Phreesia (NYSE:PHR) Price Target Lowered to $28.00 at Mizuho

Phreesia (NYSE:PHR) had its target price decreased by investment analysts at Mizuho from $36.00 to $28.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s price objective points to a potential upside of 74.08% from the company’s current price.

A number of other analysts also recently commented on PHR. Piper Sandler boosted their target price on shares of Phreesia from $33.00 to $34.00 and gave the stock an “overweight” rating in a report on Friday, September 5th. KeyCorp decreased their price target on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Raymond James Financial set a $33.00 price objective on Phreesia and gave the company an “outperform” rating in a research report on Friday, September 5th. Truist Financial raised their price objective on Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a research note on Friday, September 5th. Finally, Zacks Research upgraded Phreesia from a “hold” rating to a “strong-buy” rating in a report on Monday. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $31.56.

Phreesia Stock Up 4.2%

PHR opened at $16.09 on Wednesday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.12 and a current ratio of 2.12. The company has a market capitalization of $963.65 million, a PE ratio of -161.03 and a beta of 0.64. The stock’s fifty day moving average is $21.87 and its 200-day moving average is $25.19. Phreesia has a one year low of $15.41 and a one year high of $32.76.

Phreesia (NYSE:PHR) last released its earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.11. Phreesia had a negative return on equity of 1.36% and a negative net margin of 1.16%.The firm had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. During the same period in the previous year, the company earned ($0.25) earnings per share. Phreesia’s revenue was up 12.7% compared to the same quarter last year. On average, equities analysts predict that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Transactions at Phreesia

In other Phreesia news, insider David Linetsky sold 2,165 shares of the stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total value of $50,401.20. Following the completion of the sale, the insider owned 174,952 shares in the company, valued at $4,072,882.56. This represents a 1.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Amy Beth Vanduyn sold 1,762 shares of Phreesia stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $41,019.36. Following the sale, the senior vice president directly owned 112,479 shares of the company’s stock, valued at $2,618,511.12. This trade represents a 1.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 26,174 shares of company stock worth $603,835. 5.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of PHR. Tudor Investment Corp ET AL purchased a new stake in shares of Phreesia during the 3rd quarter worth about $4,173,000. Connors Investor Services Inc. increased its holdings in Phreesia by 35.6% in the third quarter. Connors Investor Services Inc. now owns 110,023 shares of the company’s stock worth $2,588,000 after buying an additional 28,861 shares during the last quarter. Dark Forest Capital Management LP raised its position in Phreesia by 217.5% during the third quarter. Dark Forest Capital Management LP now owns 23,410 shares of the company’s stock valued at $551,000 after acquiring an additional 16,037 shares in the last quarter. PharVision Advisers LLC acquired a new stake in Phreesia in the third quarter valued at approximately $345,000. Finally, Virtus Advisers LLC grew its position in Phreesia by 522.8% in the third quarter. Virtus Advisers LLC now owns 14,181 shares of the company’s stock worth $334,000 after acquiring an additional 11,904 shares in the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.